Prognostic factors in neuroblastoma: The need for evidencebased decisions in prospective studies

Clinical and Translational Oncology

Volumn 7, Issue 1, 2005, Pages 1-2

  Melcón, Soledad Gallego ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

CHILD; EVIDENCE BASED MEDICINE; HUMAN; NEUROBLASTOMA; NOTE; PROGNOSIS; PROSPECTIVE STUDY;

BIOLOGICAL MARKERS; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; NEUROBLASTOMA; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 22244486674     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/BF02710018     Document Type: Editorial

References (2)

1. Riley R, Heney D, Jones D, et al. A systematic review of molecular and biological tumor markers in neuroblastoma. Clin Cancer Res 2004;10:4-12. (Pubitemid 38114154)
2. Olaya-Vargas A, Rivera-Luna R, Cárdenas-Cardós R, et al. Prognostic factors including neoadjuvant chemotherapy in Mexican children with neuroblastoma. Clin Transl Oncol 2005;7:12-7.